Tb-PSMA I&T acetate
Reference Standard for [161Tb]-PSMA I&T (PSMA: prostate-specific membrane antigen I&T: Imaging and Therapy)
159Tb-(R)-DOTAGA-(I-y)fk(Sub-KuE)
Sequence: (R)-DOTAGA(159Tb)-D-Tyr(3-I)-D-Phe-D-Lys[Sub-Glu-CO-Lys] acetate
Quality
Research Chemical
Characteristics
Molar mass 1654,29
CAS RN [not yet assigned]
Purity ≥ 95 %
- White to off-white solid
- water, DMSO
Certificates
CoA: appearance, MS (identity), HPLC (purity)
Literature
James P Buteau, MD et.al.First-in-human results of terbium-161 [161Tb]Tb-PSMA-I&T dual beta–Auger radioligand therapy in patients with metastatic castration-resistant prostate cancer (VIOLET): a single-centre, single-arm, phase 1/2 study. The Lancet Oncology, 2025; 26, 1009-1017
Schottelius M. et al. [¹¹¹In] PSMA-I&T: expanding the spectrum of PSMA-I&T applications towards SPECT and radioguided surgery. EJNMMI Res. 2015, 5, 68.
Add to inquiry
| Product | Product No. | Filling amount | Quantity | ||
|---|---|---|---|---|---|
| /products/small-molecules-and-peptides/chemical/8c88f51a-43ad-475c-9292-ca3a8f9c533b | Reference Standard | Product No.: 99397 |